Top

Reactions Weekly

Published in:

01-08-2022 | Hirsutism | Case report

Risperidone

Hyperprolactinaemia: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Altun IK, et al. Decrease in Prolactin Levels after Switching from Long-Acting Injectable Risperidone to Paliperidone Palmitate: A Case Report?. Psychiatry and Clinical Psychopharmacology 27 (Suppl. 1): 134 abstr. 0217, May 2017. Available from: URL: http://doi.org/10.1080/24750573.2017.1308709 [abstract]

Title: Risperidone
Hyperprolactinaemia: case report
Publication date: 01-08-2022
Publisher: Springer International Publishing
Keywords: Hirsutism
Amenorrhoea
Paliperidone
Risperidone
Valproate
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-21471-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Risperidone

Hyperprolactinaemia: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Multiple drugs

Nivolumab

Rivaroxaban/warfarin

Pembrolizumab

Mitoxantrone

Antineoplastics